Zepbound Mounjaro
-
{
- All
- News
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
